Aspire Biopharma Holdings ASBP Cash Flow Statement (2021-2026)

NASDAQ ASBP

$7.97 +0.15 (+1.92%)

At close: Aug 21, 2026 · 4:00 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Mar2022	Sep2023	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)				-0.00B	-0.00B	-0.02B		-0.00B	-0.01B	-0.00B	-0.00B
Share-based Compensation (Quarter)						14,131.25B	-14131.24B		-0.00B	0.00B	0.00B
Asset Writedowns and Impairment (Quarter)											0.00B
Cash from Operations (Quarter)											-0.00B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)						0.00B		0.00B	0.01B	0.00B
Change in Working Capital
Change in Inventory (Quarter)											-0.00B
Change in Account Payables (Quarter)											0.00B
Change in Accured Expenses (Quarter)											0.00B
Other Working Capital Changes (Quarter)											0.00B
Investing Activities
Cash from Investing Activities (Quarter)	0.00B	-0.29B	0.00B
Financing Activities
Other financing activities (Quarter)		0.01B				0.00B		-1.00
Cash from Financing Activities (Quarter)											0.01B
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)											0.01B
Additional items
Change in Cash (Quarter)											0.01B
Free Cash Flow (Quarter)											-0.00B
Net Cash Flow (Quarter)											0.01B